Perinatal Morbidity in Healthy Obese Pregnant Individuals Delivered by Elective Repeat Cesarean at Term. 2024

Rebecca E Fleenor, and Duncan T Harmon, and Melissa Gazi, and Jeff Szychowski, and Lorie M Harper, and Alan T N Tita, and Akila Subramaniam
Department of Obstetrics and Gynecology, Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, Alabama.

OBJECTIVE This study aimed to compare the risks of adverse perinatal outcomes by body mass index (BMI) categories in healthy pregnant individuals delivered by term elective repeat cesarean (ERCD) to describe an optimal timing of delivery in otherwise healthy patients at the highest-risk BMI threshold. METHODS A secondary analysis of a prospective cohort of pregnant individuals undergoing ERCD at 19 centers in the Maternal-Fetal Medicine Units Network from 1999 to 2002. Nonanomalous singletons undergoing prelabor ERCD at term were included. The primary outcome was composite neonatal morbidity; secondary outcomes included composite maternal morbidity and individual components of the composites. Patients were stratified by BMI classes and to identify a BMI threshold for which morbidity was the highest. Outcomes were then examined by completed week's gestation, between BMI classes. Multivariable logistic regression was used to calculate adjusted odds ratios (aOR) and 95% confidence intervals (CI). RESULTS A total of 12,755 patients were included in analysis. Patient's with BMI ≥ 40 had the highest rates of newborn sepsis, neonatal intensive care unit admissions, and wound complications. While a weight-related response was observed between BMI class and neonatal composite morbidity (p < 0.001), only those with BMI ≥ 40 had significantly higher odds of composite neonatal morbidity (aOR: 1.4, 95% CI: 1.0-1.8). In analyses of patients with BMI ≥ 40 (n = 1,848), there was no difference in the incidence of composite neonatal or maternal morbidity across weeks' gestation at delivery; however, as gestational age approached 39 to 40 weeks, rates of adverse neonatal outcomes decreased, only to increase again at 41 weeks' gestation. Of note, the odds of the primary neonatal composite were the highest at 38 weeks compared with 39 weeks (aOR: 1.5, 95% CI: 1.1-2.0). CONCLUSIONS Neonatal morbidity is significantly higher in pregnant individuals with BMI ≥40 delivering by ERCD. Despite this increased perinatal morbidity, delivery prior to 39 and after 41 weeks in these patients is associated with increased neonatal risks. CONCLUSIONS · Obese patients without additional comorbidities have higher rates of neonatal morbidity.. · Patients with BMI ≥ 40 carry the highest odds of poor perinatal outcomes.. · Earlier timing of delivery does not appear to reduce this risk..

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D007363 Intensive Care Units, Neonatal Hospital units providing continuing surveillance and care to acutely ill newborn infants. Neonatal Intensive Care Unit,Neonatal Intensive Care Units,Newborn Intensive Care Unit,Newborn Intensive Care Units,ICU, Neonatal,Neonatal ICU,Newborn ICU,Newborn Intensive Care Units (NICU),ICU, Newborn,ICUs, Neonatal,ICUs, Newborn,Neonatal ICUs,Newborn ICUs
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages

Related Publications

Rebecca E Fleenor, and Duncan T Harmon, and Melissa Gazi, and Jeff Szychowski, and Lorie M Harper, and Alan T N Tita, and Akila Subramaniam
May 1988, Obstetrics and gynecology,
Rebecca E Fleenor, and Duncan T Harmon, and Melissa Gazi, and Jeff Szychowski, and Lorie M Harper, and Alan T N Tita, and Akila Subramaniam
April 2009, The New England journal of medicine,
Rebecca E Fleenor, and Duncan T Harmon, and Melissa Gazi, and Jeff Szychowski, and Lorie M Harper, and Alan T N Tita, and Akila Subramaniam
December 2010, La Tunisie medicale,
Rebecca E Fleenor, and Duncan T Harmon, and Melissa Gazi, and Jeff Szychowski, and Lorie M Harper, and Alan T N Tita, and Akila Subramaniam
January 2015, Acta medica portuguesa,
Rebecca E Fleenor, and Duncan T Harmon, and Melissa Gazi, and Jeff Szychowski, and Lorie M Harper, and Alan T N Tita, and Akila Subramaniam
January 2009, The New England journal of medicine,
Rebecca E Fleenor, and Duncan T Harmon, and Melissa Gazi, and Jeff Szychowski, and Lorie M Harper, and Alan T N Tita, and Akila Subramaniam
November 1976, The New England journal of medicine,
Rebecca E Fleenor, and Duncan T Harmon, and Melissa Gazi, and Jeff Szychowski, and Lorie M Harper, and Alan T N Tita, and Akila Subramaniam
June 2011, Obstetrics and gynecology,
Rebecca E Fleenor, and Duncan T Harmon, and Melissa Gazi, and Jeff Szychowski, and Lorie M Harper, and Alan T N Tita, and Akila Subramaniam
August 2016, Seminars in perinatology,
Rebecca E Fleenor, and Duncan T Harmon, and Melissa Gazi, and Jeff Szychowski, and Lorie M Harper, and Alan T N Tita, and Akila Subramaniam
February 2011, Obstetrics and gynecology,
Rebecca E Fleenor, and Duncan T Harmon, and Melissa Gazi, and Jeff Szychowski, and Lorie M Harper, and Alan T N Tita, and Akila Subramaniam
May 2024, American journal of perinatology,
Copied contents to your clipboard!